What is really in control of skin immunity: lymphocytes, dendritic cells, or keratinocytes? facts and controversies

Clinics in Dermatology

Volumn 28, Issue 1, 2010, Pages 62-66

  Rupec, Rudolf A ^a   Boneberger, Susanne ^a   Ruzicka, Thomas ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA DEFENSIN 2; BETA DEFENSIN 3; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; FILAGGRIN;

ADAPTIVE IMMUNITY; ARTICLE; ATOPIC DERMATITIS; CELLULAR IMMUNITY; CLINICAL FEATURE; DENDRITIC CELL; ENVIRONMENTAL FACTOR; GENE MUTATION; GENETIC PREDISPOSITION; GENOTYPE ENVIRONMENT INTERACTION; HISTOPATHOLOGY; HUMAN; IMMUNOMODULATION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; KERATINOCYTE; MUTATIONAL ANALYSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; T LYMPHOCYTE;

ANIMALS; ANTIMICROBIAL CATIONIC PEPTIDES; BETA-DEFENSINS; CATHELICIDINS; CYTOKINES; DENDRITIC CELLS; DERMATITIS, ATOPIC; HUMANS; IMMUNITY, INNATE; INTERMEDIATE FILAMENT PROTEINS; KERATINOCYTES; LYMPHOCYTES; SKIN;

EID: 71749110734     PISSN: 0738081X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clindermatol.2009.04.004     Document Type: Article

References (59)

1. Larsen F.S., Holm N.V., and Henningsen K. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 15 (1986) 487-494
2. Akdis C.A., Akdis M., Bieber T., et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 61 (2006) 969-987
3. Illi S., von Mutius E., Lau S., et al. The natural course of atopic dermatitis from birth to age 7 years and the association with asthma. J Allergy Clin Immunol 113 (2004) 925-931
4. Morar N., Willis-Owen S.A., Moffatt M.F., and Cookson W.O. The genetics of atopic dermatitis. J Allergy Clin Immunol 118 (2006) 24-34 [quiz 35-6]
5. Maintz L., and Novak N. Getting more and more complex: the pathophysiology of atopic eczema. Eur J Dermatol 17 (2007) 267-283
6. Wadonda-Kabondo N., Sterne J.A., Golding J., Kennedy C.T., Archer C.B., and Dunnill M.G. Association of parental eczema, hayfever, and asthma with atopic dermatitis in infancy: birth cohort study. Arch Dis Child 89 (2004) 917-921
7. Lee Y.A., Wahn U., Kehrt R., et al. A major susceptibility locus for atopic dermatitis maps to chromosome 3q21. Nat Genet 26 (2000) 470-473
8. Cookson W.O., Ubhi B., Lawrence R., et al. Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27 (2001) 372-373
9. Bu L.M., Bradley M., Soderhall C., Wahlgren C.F., Kockum I., and Nordenskjold M. Genome-wide linkage analysis of allergic rhinoconjunctivitis in a Swedish population. Clin Exp Allergy 36 (2006) 204-210
10. Bradley M., Soderhall C., Luthman H., Wahlgren C.F., Kockum I., and Nordenskjold M. Susceptibility loci for atopic dermatitis on chromosomes 3, 13, 15, 17 and 18 in a Swedish population. Hum Mol Genet 11 (2002) 1539-1548
11. Haagerup A., Bjerke T., Schiotz P.O., et al. Atopic dermatitis-a total genome-scan for susceptibility genes. Acta Derm Venereol 84 (2004) 346-352
12. Palmer L.J., and Cardon L.R. Shaking the tree: mapping complex disease genes with linkage disequilibrium. Lancet 366 (2005) 1223-1234
13. Bowcock A.M., and Cookson W.O. The genetics of psoriasis, psoriatic arthritis and atopic dermatitis. Hum Mol Genet 13 (2004) R43-R55
14. Johansson S.G., Bieber T., Dahl R., et al. Revised nomenclature for allergy for global use: Report of the Nomenclature Review Committee of the World Allergy Organization, October 2003. J Allergy Clin Immunol 113 (2004) 832-836
15. Weedon D. Skin pathology. 2nd ed (2002), Churchill Livingstone, London
16. Elias P.M., and Steinhoff M. "Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128 (2008) 1067-1070
17. Aly R., Maibach H.I., and Shinefield H.R. Microbial flora of atopic dermatitis. Arch Dermatol 113 (1977) 780-782
18. Baker B.S. The role of microorganisms in atopic dermatitis. Clin Exp Immunol 144 (2006) 1-9
19. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446
20. Weidinger S., Baurecht H., Wagenpfeil S., et al. Analysis of the individual and aggregate genetic contributions of previously identified serine peptidase inhibitor Kazal type 5 (SPINK5), kallikrein-related peptidase 7 (KLK7), and filaggrin (FLG) polymorphisms to eczema risk. J Allergy Clin Immunol 122 (2008) 560-568.e4
21. Scott I.R., and Harding C.R. Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115 (1986) 84-92
22. Walley A.J., Chavanas S., Moffatt M.F., et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 29 (2001) 175-178
23. Demerjian M., Hachem J.P., Tschachler E., et al. Acute modulations in permeability barrier function regulate epidermal cornification: role of caspase-14 and the protease-activated receptor type 2. Am J Pathol 172 (2008) 86-97
24. Nylander-Lundqvist E., Back O., and Egelrud T. IL-1b activation in human epidermis. J Immunol 157 (1996) 1699-1704
25. Hachem J.P., Crumrine D., Fluhr J., Brown B.E., Feingold K.R., and Elias P.M. pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol 121 (2003) 345-353
26. Miller S.J., Aly R., Shinefeld H.R., and Elias P.M. In vitro and in vivo antistaphylococcal activity of human stratum corneum lipids. Arch Dermatol 124 (1988) 209-215
27. Bibel D.J., Aly R., and Shinefield H.R. Antimicrobial activity of sphingosines. J Invest Dermatol 98 (1992) 269-273
28. Ong P.Y., Ohtake T., Brandt C., et al. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
29. Howell M.D., Gallo R.L., Boguniewicz M., et al. Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus. Immunity 24 (2006) 341-348
30. Nomura I., Goleva E., Howell M.D., et al. Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol 171 (2003) 3262-3269
31. Zaiou M., Nizet V., and Gallo R.L. Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence. J Invest Dermatol 120 (2003) 810-816
32. Komatsuzawa H., Ouhara K., Yamada S., et al. Innate defences against methicillin-resistant Staphylococcus aureus (MRSA) infection. J Pathol 208 (2006) 249-260
33. Kisich K.O., Howell M.D., Boguniewicz M., Heizer H.R., Watson N.U., and Leung D.Y. The constitutive capacity of human keratinocytes to kill Staphylococcus aureus is dependent on beta-defensin 3. J Invest Dermatol 127 (2007) 2368-2380
34. Ou L.S., Goleva E., Hall C., and Leung D.Y. T regulatory cells in atopic dermatitis and subversion of their activity by superantigens. J Allergy Clin Immunol 113 (2004) 756-763
35. Taskapan M.O., and Kumar P. Role of staphylococcal superantigens in atopic dermatitis: from colonization to inflammation. Ann Allergy Asthma Immunol 84 (2000) 3-10 [quiz 11-2]
36. Herrmann T., and MacDonald H.R. T cell recognition of superantigens. Curr Top Microbiol Immunol 174 (1991) 21-38
37. Rieg S., Garbe C., Sauer B., Kalbacher H., and Schittek B. Dermcidin is constitutively produced by eccrine sweat glands and is not induced in epidermal cells under inflammatory skin conditions. Br J Dermatol 151 (2004) 534-539
38. Imayama S., Shimozono Y., Hoashi M., et al. Reduced secretion of IgA to skin surface of patients with atopic dermatitis. J Allergy Clin Immunol 94 (1994) 195-200
39. Liebke C., Wahn U., and Niggemann B. Sweat electrolyte concentrations in children with atopic dermatitis. Lancet 350 (1997) 1678-1679
40. Bunikowski R., Mielke M.E., Skarabis H., et al. Evidence for a disease-promoting effect of Staphylococcus aureus-derived exotoxins in atopic dermatitis. J Allergy Clin Immunol 105 (2000) 814-819
41. Zollner T.M., Wichelhaus T.A., Hartung A., et al. Colonization with superantigen-producing Staphylococcus aureus is associated with increased severity of atopic dermatitis. Clin Exp Allergy 30 (2000) 994-1000
42. Aliprantis A.O., Yang R.B., Mark M.R., et al. Cell activation and apoptosis by bacterial lipoproteins through toll-like receptor-2. Science 285 (1999) 736-739
43. Kawai K., Shimura H., Minagawa M., Ito A., Tomiyama K., and Ito M. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 30 (2002) 185-194
44. Biedermann T. Dissecting the role of infections in atopic dermatitis. Acta Derm Venereol 86 (2006) 99-109
45. Lebre M.C., van Capel T.M., Bos J.D., Knol E.F., Kapsenberg M.L., and de Jong E.C. Aberrant function of peripheral blood myeloid and plasmacytoid dendritic cells in atopic dermatitis patients. J Allergy Clin Immunol 122 (2008) 969-976.e5
46. Novak N., Peng W., and Yu C. Network of myeloid and plasmacytoid dendritic cells in atopic dermatitis. Adv Exp Med Biol 601 (2007) 97-104
47. Merad M., Ginhoux F., and Collin M. Origin, homeostasis and function of Langerhans cells and other langerin-expressing dendritic cells. Nat Rev Immunol 8 (2008) 935-947
48. Wollenberg A., Kraft S., Hanau D., and Bieber T. Immunomorphological and ultrastructural characterization of Langerhans cells and a novel, inflammatory dendritic epidermal cell (IDEC) population in lesional skin of atopic eczema. J Invest Dermatol 106 (1996) 446-453
49. Bieber T., de la Salle H., Wollenberg A., et al. Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI). J Exp Med 175 (1992) 1285-1290
50. Schuler G., and Steinman R.M. Murine epidermal Langerhans cells mature into potent immunostimulatory dendritic cells in vitro. J Exp Med 161 (1985) 526-546
51. Grewe M., Walther S., Gyufko K., Czech W., Schopf E., and Krutmann J. Analysis of the cytokine pattern expressed in situ in inhalant allergen patch test reactions of atopic dermatitis patients. J Invest Dermatol 105 (1995) 407-410
52. Novak N., and Bieber T. The role of dendritic cell subtypes in the pathophysiology of atopic dermatitis. J Am Acad Dermatol 53 2 suppl 2 (2005) S171-S176
53. Kakinuma T., Nakamura K., Wakugawa M., et al. Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity. J Allergy Clin Immunol 107 (2001) 535-541
54. Novak N., Allam J.P., Hagemann T., et al. Characterization of FceRI-bearing CD123 blood dendritic cell antigen-2 plasmacytoid dendritic cells in atopic dermatitis. J Allergy Clin Immunol 114 (2004) 364-370
55. Wollenberg A., Zoch C., Wetzel S., Plewig G., and Przybilla B. Predisposing factors and clinical features of eczema herpeticum: a retrospective analysis of 100 cases. J Am Acad Dermatol 49 (2003) 198-205
56. Homey B., Steinhoff M., Ruzicka T., and Leung D.Y. Cytokines and chemokines orchestrate atopic skin inflammation. J Allergy Clin Immunol 118 (2006) 178-189
57. Wood L.C., Jackson S.M., Elias P.M., Grunfeld C., and Feingold K.R. Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90 (1992) 482-487
58. Wood L.C., Elias P.M., Calhoun C., Tsai J.C., Grunfeld C., and Feingold K.R. Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol 106 (1996) 397-403
59. Akdis M., Trautmann A., Klunker S., et al. T helper (Th) 2 predominance in atopic diseases is due to preferential apoptosis of circulating memory/effector Th1 cells. FASEB J 17 (2003) 1026-1035